Zobrazeno 1 - 10
of 44
pro vyhledávání: '"Ries, Ch"'
Publikováno v:
British Journal of Cancer. 4/7/2003, Vol. 88 Issue 7, p1084-1090. 7p.
Autor:
Ries, Christian.
Publikováno v:
Kostenfrei.
Zugl.: Wien, Univ. für Bodenkultur, Diss., 1991.
Externí odkaz:
http://www.gbv.de/dms/bs/toc/025920189.pdf
Autor:
Ries, Christoph
Inaug.-diss.--Erlangen.
Lebenslauf. "Literaturübersicht": p. [9]-11.
Lebenslauf. "Literaturübersicht": p. [9]-11.
Externí odkaz:
http://catalog.hathitrust.org/api/volumes/oclc/28797240.html
Autor:
Domingos-Pereira S; Department of Urology, Lausanne University Hospital, University of Lausanne, 1010 Lausanne, Switzerland., Sathiyanadan K; Department of Urology, Lausanne University Hospital, University of Lausanne, 1010 Lausanne, Switzerland., Polak L; Department of Urology, Lausanne University Hospital, University of Lausanne, 1010 Lausanne, Switzerland., Haefliger JA; Department of Medicine, Lausanne University Hospital, University of Lausanne, 1010 Lausanne, Switzerland., Schmittnaegel M; Roche Innovation Center Munich, Pharma Research and Early Development, 82377 Penzberg, Germany., Ries CH; Roche Innovation Center Munich, Pharma Research and Early Development, 82377 Penzberg, Germany., Jichlinski P; Department of Urology, Lausanne University Hospital, University of Lausanne, 1010 Lausanne, Switzerland., Roth B; Department of Urology, Lausanne University Hospital, University of Lausanne, 1010 Lausanne, Switzerland., Derré L; Department of Urology, Lausanne University Hospital, University of Lausanne, 1010 Lausanne, Switzerland., Nardelli-Haefliger D; Department of Urology, Lausanne University Hospital, University of Lausanne, 1010 Lausanne, Switzerland.
Publikováno v:
International journal of molecular sciences [Int J Mol Sci] 2022 Dec 21; Vol. 24 (1). Date of Electronic Publication: 2022 Dec 21.
Autor:
Murgaski A; Myeloid Cell Immunology Lab, VIB Center for Inflammation Research, Brussels, Belgium.; Lab of Cellular and Molecular Immunology, Vrije Universiteit Brussel, Brussels, Belgium., Kiss M; Myeloid Cell Immunology Lab, VIB Center for Inflammation Research, Brussels, Belgium.; Lab of Cellular and Molecular Immunology, Vrije Universiteit Brussel, Brussels, Belgium., Van Damme H; Myeloid Cell Immunology Lab, VIB Center for Inflammation Research, Brussels, Belgium.; Lab of Cellular and Molecular Immunology, Vrije Universiteit Brussel, Brussels, Belgium., Kancheva D; Myeloid Cell Immunology Lab, VIB Center for Inflammation Research, Brussels, Belgium.; Lab of Cellular and Molecular Immunology, Vrije Universiteit Brussel, Brussels, Belgium., Vanmeerbeek I; Laboratory of Cell Stress & Immunity (CSI), Department of Cellular & Molecular Medicine, KU Leuven, Leuven, Belgium., Keirsse J; Myeloid Cell Immunology Lab, VIB Center for Inflammation Research, Brussels, Belgium.; Lab of Cellular and Molecular Immunology, Vrije Universiteit Brussel, Brussels, Belgium., Hadadi E; Myeloid Cell Immunology Lab, VIB Center for Inflammation Research, Brussels, Belgium.; Lab of Cellular and Molecular Immunology, Vrije Universiteit Brussel, Brussels, Belgium., Brughmans J; Myeloid Cell Immunology Lab, VIB Center for Inflammation Research, Brussels, Belgium.; Lab of Cellular and Molecular Immunology, Vrije Universiteit Brussel, Brussels, Belgium., Arnouk SM; Myeloid Cell Immunology Lab, VIB Center for Inflammation Research, Brussels, Belgium.; Lab of Cellular and Molecular Immunology, Vrije Universiteit Brussel, Brussels, Belgium., Hamouda AEI; Myeloid Cell Immunology Lab, VIB Center for Inflammation Research, Brussels, Belgium.; Lab of Cellular and Molecular Immunology, Vrije Universiteit Brussel, Brussels, Belgium., Debraekeleer A; Myeloid Cell Immunology Lab, VIB Center for Inflammation Research, Brussels, Belgium.; Lab of Cellular and Molecular Immunology, Vrije Universiteit Brussel, Brussels, Belgium., Bosteels V; Laboratory for ER stress and Inflammation, VIB Center for Inflammation Research, Ghent, Belgium.; Department of Internal Medicine and Pediatrics, Ghent University, Ghent, Belgium., Elkrim Y; Myeloid Cell Immunology Lab, VIB Center for Inflammation Research, Brussels, Belgium.; Lab of Cellular and Molecular Immunology, Vrije Universiteit Brussel, Brussels, Belgium., Boon L; JJP Biologics, Warsaw, Poland., Hoves S; Roche Pharmaceutical Research and Early Development, Discovery Oncology, Roche Innovation Center Munich, Penzberg, Germany., Vandamme N; Data Mining and Modeling for Biomedicine, VIB Center for Inflammation Research, Ghent, Belgium.; Department of Applied Mathematics, Computer Science and Statistics, Ghent University, Ghent, Belgium., Deschoemaeker S; Myeloid Cell Immunology Lab, VIB Center for Inflammation Research, Brussels, Belgium.; Lab of Cellular and Molecular Immunology, Vrije Universiteit Brussel, Brussels, Belgium., Janssens S; Laboratory for ER stress and Inflammation, VIB Center for Inflammation Research, Ghent, Belgium.; Department of Internal Medicine and Pediatrics, Ghent University, Ghent, Belgium., Garg AD; Laboratory of Cell Stress & Immunity (CSI), Department of Cellular & Molecular Medicine, KU Leuven, Leuven, Belgium., Vande Velde G; Department of Imaging and Pathology, Faculty of Medicine, KU Leuven, Leuven, Belgium., Schmittnaegel M; Roche Pharmaceutical Research and Early Development, Discovery Oncology, Roche Innovation Center Munich, Penzberg, Germany., Ries CH; Roche Pharmaceutical Research and Early Development, Discovery Oncology, Roche Innovation Center Munich, Penzberg, Germany., Laoui D; Myeloid Cell Immunology Lab, VIB Center for Inflammation Research, Brussels, Belgium.; Lab of Cellular and Molecular Immunology, Vrije Universiteit Brussel, Brussels, Belgium.
Publikováno v:
Cancer research [Cancer Res] 2022 Oct 17; Vol. 82 (20), pp. 3785-3801.
Autor:
Kos K; Division of Tumor Biology & Immunology, Netherlands Cancer Institute, Amsterdam, The Netherlands.; Oncode Institute, Utrecht, The Netherlands.; Department of Immunology, Leiden University Medical Center, Leiden, The Netherlands., Salvagno C; Division of Tumor Biology & Immunology, Netherlands Cancer Institute, Amsterdam, The Netherlands.; Oncode Institute, Utrecht, The Netherlands.; Department of Obstetrics and Gynecology, Sandra and Edward Meyer Cancer Center, Weill Cornell Medicine, New York, NY, United States., Wellenstein MD; Division of Tumor Biology & Immunology, Netherlands Cancer Institute, Amsterdam, The Netherlands.; Oncode Institute, Utrecht, The Netherlands.; Hubrecht Institute, Royal Netherlands Academy of Arts and Sciences (KNAW), University Medical Center Utrecht, Utrecht, The Netherlands., Aslam MA; Division of Tumor Biology & Immunology, Netherlands Cancer Institute, Amsterdam, The Netherlands., Meijer DA; Division of Tumor Biology & Immunology, Netherlands Cancer Institute, Amsterdam, The Netherlands.; Oncode Institute, Utrecht, The Netherlands., Hau CS; Division of Tumor Biology & Immunology, Netherlands Cancer Institute, Amsterdam, The Netherlands.; Oncode Institute, Utrecht, The Netherlands., Vrijland K; Division of Tumor Biology & Immunology, Netherlands Cancer Institute, Amsterdam, The Netherlands.; Oncode Institute, Utrecht, The Netherlands., Kaldenbach D; Division of Tumor Biology & Immunology, Netherlands Cancer Institute, Amsterdam, The Netherlands.; Oncode Institute, Utrecht, The Netherlands., Raeven EAM; Division of Tumor Biology & Immunology, Netherlands Cancer Institute, Amsterdam, The Netherlands.; Oncode Institute, Utrecht, The Netherlands., Schmittnaegel M; Roche Innovation Center Munich, Roche Pharma Research and Early Development, Penzberg, Germany., Ries CH; Roche Innovation Center Munich, Roche Pharma Research and Early Development, Penzberg, Germany., de Visser KE; Division of Tumor Biology & Immunology, Netherlands Cancer Institute, Amsterdam, The Netherlands.; Oncode Institute, Utrecht, The Netherlands.; Department of Immunology, Leiden University Medical Center, Leiden, The Netherlands.
Publikováno v:
Oncoimmunology [Oncoimmunology] 2022 Apr 15; Vol. 11 (1), pp. 2063225. Date of Electronic Publication: 2022 Apr 15 (Print Publication: 2022).
Autor:
Martinez-Usatorre A; Swiss Institute for Experimental Cancer Research (ISREC), School of Life Sciences, Swiss Federal Institute of Technology in Lausanne (EPFL), 1015 Lausanne, Switzerland.; Agora Cancer Research Center, 1011 Lausanne, Switzerland., Kadioglu E; Swiss Institute for Experimental Cancer Research (ISREC), School of Life Sciences, Swiss Federal Institute of Technology in Lausanne (EPFL), 1015 Lausanne, Switzerland., Boivin G; Swiss Institute for Experimental Cancer Research (ISREC), School of Life Sciences, Swiss Federal Institute of Technology in Lausanne (EPFL), 1015 Lausanne, Switzerland.; Agora Cancer Research Center, 1011 Lausanne, Switzerland., Cianciaruso C; Swiss Institute for Experimental Cancer Research (ISREC), School of Life Sciences, Swiss Federal Institute of Technology in Lausanne (EPFL), 1015 Lausanne, Switzerland.; Agora Cancer Research Center, 1011 Lausanne, Switzerland., Guichard A; Swiss Institute for Experimental Cancer Research (ISREC), School of Life Sciences, Swiss Federal Institute of Technology in Lausanne (EPFL), 1015 Lausanne, Switzerland.; Agora Cancer Research Center, 1011 Lausanne, Switzerland., Torchia B; Swiss Institute for Experimental Cancer Research (ISREC), School of Life Sciences, Swiss Federal Institute of Technology in Lausanne (EPFL), 1015 Lausanne, Switzerland.; Agora Cancer Research Center, 1011 Lausanne, Switzerland., Zangger N; Bioinformatics Core Facility (BCF), SIB Swiss Institute of Bioinformatics, 1015 Lausanne, Switzerland., Nassiri S; Swiss Institute for Experimental Cancer Research (ISREC), School of Life Sciences, Swiss Federal Institute of Technology in Lausanne (EPFL), 1015 Lausanne, Switzerland.; Agora Cancer Research Center, 1011 Lausanne, Switzerland.; Bioinformatics Core Facility (BCF), SIB Swiss Institute of Bioinformatics, 1015 Lausanne, Switzerland., Keklikoglou I; Swiss Institute for Experimental Cancer Research (ISREC), School of Life Sciences, Swiss Federal Institute of Technology in Lausanne (EPFL), 1015 Lausanne, Switzerland., Schmittnaegel M; Swiss Institute for Experimental Cancer Research (ISREC), School of Life Sciences, Swiss Federal Institute of Technology in Lausanne (EPFL), 1015 Lausanne, Switzerland.; Roche Innovation Center Munich, Oncology Discovery, Pharma Research and Early Development, 82377 Penzberg, Germany., Ries CH; Roche Innovation Center Munich, Oncology Discovery, Pharma Research and Early Development, 82377 Penzberg, Germany., Meylan E; Swiss Institute for Experimental Cancer Research (ISREC), School of Life Sciences, Swiss Federal Institute of Technology in Lausanne (EPFL), 1015 Lausanne, Switzerland., De Palma M; Swiss Institute for Experimental Cancer Research (ISREC), School of Life Sciences, Swiss Federal Institute of Technology in Lausanne (EPFL), 1015 Lausanne, Switzerland. michele.depalma@epfl.ch.; Agora Cancer Research Center, 1011 Lausanne, Switzerland.
Publikováno v:
Science translational medicine [Sci Transl Med] 2021 Aug 11; Vol. 13 (606).
Autor:
Ardighieri L; Unit of Pathology, ASST Spedali Civili di Brescia, Brescia, Italy., Missale F; Department of Molecular and Translational Medicine, University of Brescia, Brescia, Italy.; IRCCS Ospedale Policlinico San Martino, Genova, Italy., Bugatti M; Unit of Pathology, ASST Spedali Civili di Brescia, Brescia, Italy.; Department of Molecular and Translational Medicine, University of Brescia, Brescia, Italy., Gatta LB; Department of Molecular and Translational Medicine, University of Brescia, Brescia, Italy., Pezzali I; Department of Molecular and Translational Medicine, University of Brescia, Brescia, Italy., Monti M; Department of Molecular and Translational Medicine, University of Brescia, Brescia, Italy., Gottardi S; Diatech Pharmacogenetics srl, Jesi, Italy., Zanotti L; 'Angelo Nocivelli' Institute of Molecular Medicine, ASST Spedali Civili of Brescia- University of Brescia, Brescia, Italy.; Division of Obstetrics and Gynecology, ASST Spedali Civili di Brescia, Brescia, Italy., Bignotti E; 'Angelo Nocivelli' Institute of Molecular Medicine, ASST Spedali Civili of Brescia- University of Brescia, Brescia, Italy.; Division of Obstetrics and Gynecology, ASST Spedali Civili di Brescia, Brescia, Italy., Ravaggi A; 'Angelo Nocivelli' Institute of Molecular Medicine, ASST Spedali Civili of Brescia- University of Brescia, Brescia, Italy.; Division of Obstetrics and Gynecology, ASST Spedali Civili di Brescia, Brescia, Italy.; Department of Clinical and Experimental Science, University of Brescia, Brescia, Italy., Tognon G; Division of Obstetrics and Gynecology, ASST Spedali Civili di Brescia, Brescia, Italy., Odicino F; Division of Obstetrics and Gynecology, ASST Spedali Civili di Brescia, Brescia, Italy.; Department of Clinical and Experimental Science, University of Brescia, Brescia, Italy., Calza S; Unit of Biostatistics, Department of Molecular and Translational Medicine, University of Brescia, Brescia, Italy.; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.; Big & Open Data Innovation Laboratory, University of Brescia, Brescia, Italy., Missolo-Koussou Y; PSL University, Institut Curie Research Center, INSERM U932 & SiRIC, Center for Cancers Immunotherapy, Translational Immunotherapy Team, Paris, France., Ries CH; Dr. Carola Ries Consulting, Penzberg, Germany., Helft J; PSL University, Institut Curie Research Center, INSERM U932 & SiRIC, Center for Cancers Immunotherapy, Translational Immunotherapy Team, Paris, France., Vermi W; Unit of Pathology, ASST Spedali Civili di Brescia, Brescia, Italy.; Department of Molecular and Translational Medicine, University of Brescia, Brescia, Italy.; Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO, United States.
Publikováno v:
Frontiers in immunology [Front Immunol] 2021 Jun 18; Vol. 12, pp. 690201. Date of Electronic Publication: 2021 Jun 18 (Print Publication: 2021).
Autor:
Bissinger S; Roche Pharma Research and Early Development, Discovery Oncology, Roche Innovation Center Munich, 82377 Penzberg, Germany. bissins@gmail.com riescarola@gmx.de., Hage C; Roche Pharma Research and Early Development, Discovery Oncology, Roche Innovation Center Munich, 82377 Penzberg, Germany., Wagner V; Roche Pharma Research and Early Development, Discovery Oncology, Roche Innovation Center Munich, 82377 Penzberg, Germany., Maser IP; Roche Pharma Research and Early Development, Discovery Oncology, Roche Innovation Center Munich, 82377 Penzberg, Germany., Brand V; Roche Pharma Research and Early Development, Discovery Oncology, Roche Innovation Center Munich, 82377 Penzberg, Germany., Schmittnaegel M; Swiss Institute for Experimental Cancer Research (ISREC), School of Life Sciences, Swiss Federal Institute of Technology in Lausanne (EPFL), 1015 Lausanne, Switzerland.; Roche Pharma Research and Early Development, Discovery Oncology, Roche Innovation Center Munich, 82377 Penzberg, Germany., Jegg AM; Roche Pharma Research and Early Development, Discovery Oncology, Roche Innovation Center Munich, 82377 Penzberg, Germany., Cannarile M; Roche Pharma Research and Early Development, Discovery Oncology, Roche Innovation Center Munich, 82377 Penzberg, Germany., Watson C, Klaman I; Roche Pharma Research and Early Development, Discovery Oncology, Roche Innovation Center Munich, 82377 Penzberg, Germany., Rieder N; Roche Pharma Research and Early Development, Discovery Oncology, Roche Innovation Center Munich, 82377 Penzberg, Germany., González Loyola A; Department of Oncology, University of Lausanne (UNIL) and Ludwig Institute for Cancer Research Lausanne (LICR), 1066 Epalinges, Switzerland., Petrova TV; Department of Oncology, University of Lausanne (UNIL) and Ludwig Institute for Cancer Research Lausanne (LICR), 1066 Epalinges, Switzerland., Cassier PA; Department of Medical Oncology, Centre Léon Bérard, 69008 Lyon, France., Gomez-Roca C; Institut Claudius Regaud/Institut Universitaire du Cancer, Toulouse Oncopole, 31300 Toulouse, France., Sibaud V; Institut Claudius Regaud/Institut Universitaire du Cancer, Toulouse Oncopole, 31300 Toulouse, France., De Palma M; Swiss Institute for Experimental Cancer Research (ISREC), School of Life Sciences, Swiss Federal Institute of Technology in Lausanne (EPFL), 1015 Lausanne, Switzerland., Hoves S; Roche Pharma Research and Early Development, Discovery Oncology, Roche Innovation Center Munich, 82377 Penzberg, Germany., Ries CH; Roche Pharma Research and Early Development, Discovery Oncology, Roche Innovation Center Munich, 82377 Penzberg, Germany. bissins@gmail.com riescarola@gmx.de.
Publikováno v:
Science translational medicine [Sci Transl Med] 2021 Jun 16; Vol. 13 (598).